PMSIT
What it found
A paper reports the results; we have not read it yet. See Papers below.
What it measured
Main measures
The primary endpoint is to document safety parameters during the study
Safety
Who could take part
Progressive MS
Inclusion: A subject will be eligible for inclusion in this study if all of the following criteria apply: Exclusion: A subject will not be eligible for inclusion in this study if any of the following criteria ap-plies:
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Investigate tolerability and efficacy of intrathecally administered Mabthera in severe progressive MS where there is no available effective treatment
Papers
Loading reviews and guidelines…
Linked trials
Extended by
ITT-PMS ExtPhase 2 · Completed
Links found where a registry record names another trial's registry number.
History
Started
Apr 2009
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error